CORE LABORATORIES N.V. Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)
CORE LABORATORIES N.V. reported Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) of -$17.21 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets · last filed 2023-02-10
- CORE LABORATORIES N.V. defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2022 was -$17.21M.
- CORE LABORATORIES N.V. defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2021 was -$5.27M, a 187.20% decline from fiscal 2020.
- CORE LABORATORIES N.V. defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2020 was $6.04M, a 12.51% decline from fiscal 2019.
- CORE LABORATORIES N.V. defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2019 was $6.91M, a 206.75% increase from fiscal 2018.
| Period end | Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) 12 month |
|---|---|
| 2022-12-31 | -$17.21M 10-K · filed 2023-02-10 |
| 2021-12-31 | -$5.27M 10-K · filed 2023-02-10 |
| 2020-12-31 | $6.04M 10-K · filed 2022-02-10 |
| 2019-12-31 | $6.91M 10-K · filed 2021-02-08 |
| 2018-12-31 | $2.25M 10-K · filed 2020-02-10 |
| 2017-12-31 | $919.00K 10-K · filed 2019-02-11 |
| 2016-12-31 | $6.33M 10-K · filed 2018-02-12 |
| 2015-12-31 | -$2.28M 10-K · filed 2017-02-10 |
| 2014-12-31 | $13.57M 10-K · filed 2016-02-12 |
| 2013-12-31 | -$961.00K 10-K · filed 2015-02-17 |
| 2012-12-31 | $2.27M 10-K · filed 2014-02-13 |
| 2011-12-31 | $8.16M 10-K · filed 2013-02-19 |
| 2010-12-31 | $2.00M 10-K · filed 2012-02-15 |